ABSTRACT Guanosine 3':5'-cyclic monophosphate (cGMP) increased 7-fold in rat pineal glands incubated in the presence of I-norepinephrine. This response consisted of two components-one was stereospecific and inhibited by a-adrenergic antagonists while the other was not stereospecific and not readily inhibited by antagonists. Although 1-isoproterenol was more potent than I-norepinephrine it had less intrinsic activity and its action was not stereospecific. The increase in cGMP caused by these catecholamines, unlike that of adenosine 3': 5'-cyclic monophosphate (cAMP), was dependent upon extracellular calcium. Ouabain and high levels of potassium produced a marked, calcium-dependent increase in pineal cGMP, without affecting cAMP. There was no effect of cholinergic agonists on cGMP. Surgical denervation markedly reduced the cGMP response to stimulation by I-norepinephrine, potassium, or ouabain. This was in contrast to the enhanced response of cAMP in denervated glands. The nonspecific increase in cGMP caused by I-isoproterenol, however, was not affected by den-ervation. These data demonstrate the existence of a calciumdependent presynaptic mechanism for the generation of cGMP which may be mediated by an a-adrenergic-like receptor. In addition, the mechanisms regulating pineal cGMP appear to be physiologically distinct from those regulating cAMP.
The physiologic role of guanosine 3':5'-cyclic monophosphate (cGMP) has remained elusive despite numerous observations that several biologically active agents can increase its concentration in a variety of cell types (1) . Adenosine 3':5'-cyclic monophosphate (cAMP) is a second messenger in the action of several hormones (2) , and a similar role has been sought for cGMP. It has been proposed that cGMP functions as an independent biological mediator whose effects oppose those of cAMP (3) . Contrasting and often antagonistic regulatory influences of cGMP and cAMP have been reported in several biological systems (3) . Since the initial demonstration that acetylcholine raises myocardial cGMP in the perfused, isolated rat heart (4), cholinergic stimulation of cGMP accumulation has been observed in uterine myometrium (5), brain tissue (6) (7) (8) , and superior cervical ganglia (9) . More recently the adrenergic neurotransmitter, norepinephrine, has been shown to elevate cGMP in vas deferens (10) and cerebellar tissue (11) .
The pineal gland has proven to be a useful organ in the study of adrenergic neurotransmission and its effects upon responsive cells (12) . Located between the cerebral hemispheres, the rat pineal gland is innervated exclusively by noradrenergic nerves whose cell bodies lie in the superior cervical ganglia (13) . Beta adrenergic stimulation of the pineal leads to the induction of serotonin N-acetyltransferase (arylamine acetyltransferase; acetyl CoA:arylamine N-acetyltransferase, EC 2.3.1.5) via a cAMP-mediated mechanism (14, 15) , and ultimately to the synthesis and secretion of the hormone melatonin (14, 16) . Decreased release of norepinephrine from nerve terminals caused by prolonged exposure of the animals to light or by surgical denervation of the gland leads to a heightened (i.e., supersensitive) response to subsequent ,B-adrenergic stimulation-in terms of adenylate cyclase activation, cAMP accumulation, protein kinase activity, and N-acetyltransferase induction (17-19, M. Zatz and R. F. O'Dea, submitted for publication).
Because tissue cGMP is elevated by norepinephrine (10, 11) , the regulation of this cyclic nucleotide was examined in intact and denervated rat pineal glands. Our experiments demonstrate the existence of an apparent presynaptic mechanism for the generation of cGMP, which may be mediated by an a-adrenergic-like receptor.
MATERIALS AND METHODS
Chemicals. Tritium-labeled cGMP (specific activity 10 Ci/ mmol) was purchased from Schwarz/Mann. The [3H]cGMP was purified free of a guanosine-like contaminant by application to a Dowex AG 1X-10 (200-400 mesh) formate column. The Dowex 1-formate column was then washed and the cGMP in the eluate was eluted as previously described (20) . The formic acid was removed during lyophilization and the [3H]cGMP was dissolved in water.
Cyclic GMP and cyclic AMP were obtained from Sigma. Standard solutions of cGMP were prepared from material purified as above and their concentrations were determined spectrophotometrically utilizing an extinction coefficient of 13.7 X 103 at 252 nm. Antisera to cGMP and 125I-labeled cGMP derivative (succinyl-cGMP methyltyrosine) were purchased from Schwarz/Mann. (Table 1) .
A further assessment of the validity of this assay for cGMP was made by comparing the apparent levels of cGMP with and without purification from the pineal extracts. Cyclic GMP in pineal extracts was purified on a Dowex AG 1X-10 formate column as described above. Recovery after purification varied between 75 and 80%. There was no difference between the apparent amounts of cGMP in purified and unpurified tissue extracts (Table 1 ).
These data demonstrate that the acetylation radioimmunoassay for pineal cGMP is highly specific and that purification of pineal extracts prior to assay is unnecessary.
RESULTS
Time Course of cGMP Response to I-Norepinephrine. 1- Norepinephrine and other adrenergic agonists, such as 1-isoproterenol, provoke a rapid increase in rat pineal cAMP levels, which reaches a maximum after [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] min (15, 25) . 1-Norepinephrine can also stimulate increases in cGMP in cerebellum (11) and ductus deferens (10) . Therefore, the effects of catecholamines on cGMP in cultured pineals were examined. The addition of 10-5 M l-norepinephrine produced an 8-to 10-fold increase in cGMP within 10 min (Fig. 1) . Thereafter, a relatively stable level, three to four times control, was maintained for at least 2 hr. A 60 min incubation was routinely used in later experiments. The to those reported in rat or mouse cerebellum (26) . cAMP displays a similar time course after l-norepinephrine, although the levels of this cyclic nucleotide tend to fall slowly after 20 min incubation (Fig. 1) . Control levels of both cyclic nucleotides remained stable after the period of preincubation. Dose Response of Pineal.cGMP to l-Norepinephrine and I-Isoproterenol. To further characterize the catecholaminestimulated elevation of cGMP in rat pineal glands, the effects of both a specific fl-agonist, I-isoproterenol, and a mixed a-and ,B-agonist, I-norepinephrine, were tested at various concentrations (Fig. 2 ). I-Isoproterenol was 100 times more potent than l-norepinephrine in elevating pineal cGMP. However, the maximal response to l-norepinephrine was consistently greater, by approximately 2-fold, than the response to l-isoproterenol. This finding raised the possibility that the maximal cGMP response consisted of more than one component. a-adrenergic receptors have been implicated in the cGMP response to catecholamines (10, 11) . In addition, other data suggest a possible role of fl-adrenergic receptors in the regulation of cGMP (27) .
It has been observed that injection of l-isoproterenol (5 mg/kg of body weight, subcutaneously) increases rat pineal cGMP 2-to 3-fold within 15 min after administration (data not shown). The multiple components of the cGMP response in the rat pineal might also derive, however, from changes occurring in different cellular entities, e.g., pinealocytes and other cell types, or presynaptic and postsynaptic sites.
Effects of Adrenergic Agonists and Antagonists. To determine the roles of a-and ,B-adrenergic receptors in the elevation of pineal cGMP by catecholamines, we studied the effects of various specific agonists and antagonists ( Table 2) . Exposure of incubated glands to l-norepinephrine produced a 5-fold increase in cGMP. The d-stereoisomer of norepinephrine produced only a 3fold elevation. Thus, approximately half of the response to l-norepinephrine is stereospecific and half is nonspecific. l-Isoproterenol produced a 3-fold elevation, which was also produced by d-isoproterenol. Thus, the cGMP response to l-isoproterenol is not stereospecific. Although high concentrations of propranolol blocked the effect of l-norepinephrine, no inhibition was observed at lower doses of either d-or l-propranolol. dl-Sotalol, another specific ,B-adrenergic antagonist (28) , failed to reduce the response to l-norepinephrine. None of the ,B-antagonists tested affected the response to l-isoproterenol. Therefore, the response to l-isoproterenol does not reflect a specific ,B-adrenergic-mediated component.
The specific a-blockers, phenoxybenzamine and phentolamine, reduced the elevation of cGMP by l-norepinephrine to a level equivalent to that produced by the noncatecholamine agonists, histamine and serotonin (Table 2 ). Lower doses of phenoxybenzamine (100 nM) also inhibited the response to 1- norepinephrine. These data suggest that a stereospecific aadrenergic-like component contributes to the response. However, the a-adrenergic agonists phenylephrine and methoxamine failed to elevate pineal cGMP, even to the level achieved by the nonspecific agonists. Therefore, the stereospecific response of cGMP to l-norepinephrine cannot be attributed to the classical postsynaptic a-adrenergic receptor.
Effects of Cholinergic Agents and Melatonin. Cholinergic agonists (4) (5) (6) (7) (8) (9) , have been shown to increase-cGMP in other 452 ± 74 (6) + dl-Sotalol (10-6) 1020 ± 274 (6) l-Isoproterenol (10-7) Phenylephrine 112 ± 7 (6) + I-Propranolol (10-7) 400 ± 18 (12) Methoxamine 184 ± 18 (6) + d-Propranolol (10-7) 483 ± 22 (12) Histamine 361 ± 15 (6) + dl-Sotalol (10-6) 559 ± 33 (6) I-Norepinephrine (10-5) Serotonin 319 ± 70 (12) + Phenoxybenzamine tissues. Despite the lack of cholinergic input to the rat pineal (29) , the effects of acetylcholine and carbamlycholine were examined. Neither compound (at 10 AM) increased pineal cGMP. Cholinergic agonists also failed to increase cGMP in mouse brain (30) . Melatonin, which raises cGMP levels in peripheral blood monocytes (31), also failed to affect cGMP levels in rat pineal.
Effects of Ouabain, Potassium, and Calcium. Calciumdependent increases in cGMP have been shown in response to I-norepinephrine, ouabain, and high concentrations of potassium in brain tissue (30) . Incubation of intact rat pineals with 1 mM ouabain or 80 mM KC1 produced marked increases in cGMP levels (Fig. 3) . Although both agents increase cAMP in brain slices (30, 32) , neither compound affected pineal cAMP (ref. 33 ; data not shown). There was negligible response of cGMP to l-norepinephrine, ouabain, or 80 mM KCI in the absence of calcium (data not shown). In contrast, the response of pineal cAMP to l-norepinephrine was not blocked by the absence of calcium. In addition, 10MM phentolamine completely blocked the increase in cGMP observed after high potassium. Neither K+-free or Ca++-free medium altered the basal levels of cGMP. Therefore, in contrast to pineal cAMP, the elevation of pineal cGMP by all agents examined is Ca++-dependent.
Effects of Denervation on Pineal cGMP. The possibility that the a-adrenergic-like and nonspecific components of the cGMP response to l-norepinephrine reside in discrete cellular compartments was examined by comparing responses in intact and denervated glands. The rat pineal gland is innervated by postganglionic sympathetic fibers originating in the superior cervical ganglia (13) . Bilateral (18) , and protein kinase activity (M. Zatz and R. F. O'Dea, submitted for publication). In contrast, the accumulation of cGMP in response to l-norepinephrine is markedly reduced after ganglionectomy (Fig. 3) . Indeed, the response is quantitatively identical to the nonspecific effect of d-norepinephrine (Table 2) or of l-isoproterenol (Fig. 3) . These data indicate that the stereospecific, a-adrenergic-like component of the noradrenergic stimulation of cGMP depends upon the presence of intact nerve terminals. Furthermore, the response of cGMP to high concentrations of potassium or to ouabain is abolished after ganglionectomy (Fig. 3) . Thus, the pineal nerve terminals may be a site of cGMP accumulation.
DISCUSSION
Catecholamines elevate cGMP in cultured rat pineal glands. I-Norepinephrine has a similar effect in ductus deferens (10) and cerebellum (11) . The accumulation of cGMP in these tissues appears to be related to the stimulation of the a-adrenergic receptor. In the pineal, examination of the dose-dependent effects of l-norepinephrine and l-isoproterenol suggested that both a-and fl-adrenergic receptors might have a role in the regulation of cGMP. However, experiments with catecholamine stereoisomers and ,3-antagonists ruled against the participation of the stereospecific ,B-receptor. The effect of l-isoproterenol, like that of certain other compounds, appears to be nonspecific.
In contrast to l-isoproterenol, l-norepinephrine-affected both the nonspecific and another, stereosp-ecific, component. This stereospecific component is susceptibli to blockade by a-adrenergic antagonists. Thus, as in certain other tissues, cGMP in the pineal gland responds to catecholamines via an a-adrenergic-like mechanism.
The possibility that the nonspecific and stereospecific components reflect pre-and postsynaptic compartments was examined by comparing the increases in cGMP accumulation in denervated and sham-operated pineals. The nonspecific component was unaffected by denervation. It appears that this component does not require intact nerve endings and, therefore, may be postsynaptic.
In contrast to cGMP, the accumulation of cAMP in response to noradrenergic stimulation is greatly enhanced by denervation (18) . Thus, postsynaptic adenylate cyclase, which is-closely linked to the fl-adrenergic receptor (21) , becomes supersensitive after denervation (17) . In addition, the cAMP response to 1-norepinephrine is enhanced after prolonged exposure to light (18) , whereas alteration in lighting had no effect on either basal or stimulated cGMP levels. Furthermore, 1 mM dibutyryl cGMP had no effect on N-acetyltransferase induction in tro, under several assay conditions (R. F. O'Dea and M. Zatz, unpublished observation). Therefore, the mechanisms which enhance the sensitivity of the postsynaptic ,B-adrenergic receptor do not participate in the regulation of cGMP, nor does cGMP appear to influence the function of this receptor. The stereospecific component of the response of cGMP to l-norepinephrine was abolished by denervation, as was the response to high potassium and ouabain. Thus, the stereospecific, a-adrenergic-like component in the generation of cGMP depends upon the presence of intact nerve endings. A presynaptic role for cAMP also appears likely in view of the recent report that it can activate tyrosine hydroxylase in synaptomal fractions prepared from rat brain (34) .
High potassium and ouabain were as effective as l-norepinephrine in elevating cGMP. Although both agents produce depolarization of nervous tissue, each does so by a different mechanism. High levels of K+ depolarize by decreasing the difference between intracellular and extracellular K+ con-centrations (35) whereas ouabain inhibits (Na+-K+)adenosine triphosphatase, thereby preventing extrusion of Na+ from cells (36) . Since it has been reported that l-norepinephrine hyperpolarizes pinealocyte membranes, whereas potassium and ouabain reverse this effect (33), l-norepinephrine and the "depolarizing" agents may elevate cGMP via dissimilar mechanisms. However, the observation that each agent requires extracellular calcium and is inhibited by a-adrenergic antagonists, suggests that they may stimulate the generation of cGMP through a common mechanism. It is tempting to speculate that the presynaptic generation and action of cGMP might be related functionally to the presynaptic a-adrenergic receptor which modulates neurotransmitter release (37) .
The response of cGMP to l-norepinephrine in the pineal gland depends on extracellular calcium and consists of a stereospecific, presynaptic, a-adrenergic-like component and a second component which appears to be nonspecific, postsynaptic, and unrelated to either adrenergic receptor. The data presented here may serve to clarify some of the complexities observed in cGMP regulation in other nervous tissue (11) and elsewhere (1) . In conclusion, this report provides evidence for a catecholamine-sensitive mechanism for the generation of cGMP, which is dependent upon intact nerve terminals.
